TGFB1 and neoplasm: In a lung cancer setting, RvD1 and RvD2 suppressed the TGF-β1-induced EMT in vitro, further supporting the fact that these lipid mediators exert key anti-tumor functions that can also be independent of their anti-inflammatory properties [108].